Abstract

Based on a dendritic drug–drug conjugate, a hypoxia-responsive supramolecular nanoparticle SN@IR806-CB was constructed via the synergy of π–π stacking interaction, host–guest complexation, and hydrophobic interactions for synergistic therapies.